ドーシェンヌ筋縮症におけるプレドニゾーン

Specific immunotherapy of experimental myasthenia gravis in vitro and in vivo: the Guided Missile strategy.

Journal of neuroimmunology·2012

[A transferable "Myasthenogenic" factor in the serum of patients with myasthenia gravis.].

Journal of neurology·2010

Granzyme B: evidence for a role in the origin of myasthenia gravis.

Journal of neuroimmunology·2008

Specific immunotherapy of experimental myasthenia by genetically engineered APCs: the "guided missile" strategy.

Annals of the New York Academy of Sciences·2003

IgG from patients with Guillain-Barré syndrome interact with nicotinic acetylcholine receptor channels.

Muscle & nerve·2003

Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1.

Brain : a journal of neurology·2003

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Medication-related problems in a nephrology outpatient clinic: the role of polypharmacy and computerized prescribing system performance in a resource-limited setting.

Journal of nephrology·2026

Roles and impacts of pharmacists in attention-deficit hyperactivity disorder services: a scoping review.

International journal of clinical pharmacy·2026

Pharmacists in OPAT: a systematic review and meta-analysis.

The Journal of antimicrobial chemotherapy·2026

Willingness to Pay for Pharmacist-Led Weight Management Services in Community Pharmacies: A Cross-Sectional Study in an Academic Medical Center in Saudi Arabia.

Healthcare (Basel, Switzerland)·2026

Association Between Depressive Symptoms and Self-Reported Ongoing Medication Use Among Pharmacy Students: A Cross-Sectional Study.

Healthcare (Basel, Switzerland)·2026

Psychiatric nurses versus psychiatrists and pharmacists 'knowledge on polypharmacy practices in psychiatry: An interprofessional mixed-methods exploration.

PloS one·2026

関連する実験動画

ドーシェンヌ筋縮症におけるプレドニゾーン

関連する概念動画

Specific immunotherapy of experimental myasthenia gravis in vitro and in vivo: the Guided Missile strategy.

[A transferable "Myasthenogenic" factor in the serum of patients with myasthenia gravis.].

Granzyme B: evidence for a role in the origin of myasthenia gravis.

Specific immunotherapy of experimental myasthenia by genetically engineered APCs: the "guided missile" strategy.

IgG from patients with Guillain-Barré syndrome interact with nicotinic acetylcholine receptor channels.

Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Medication-related problems in a nephrology outpatient clinic: the role of polypharmacy and computerized prescribing system performance in a resource-limited setting.

Roles and impacts of pharmacists in attention-deficit hyperactivity disorder services: a scoping review.

Pharmacists in OPAT: a systematic review and meta-analysis.

Willingness to Pay for Pharmacist-Led Weight Management Services in Community Pharmacies: A Cross-Sectional Study in an Academic Medical Center in Saudi Arabia.

Association Between Depressive Symptoms and Self-Reported Ongoing Medication Use Among Pharmacy Students: A Cross-Sectional Study.

Psychiatric nurses versus psychiatrists and pharmacists 'knowledge on polypharmacy practices in psychiatry: An interprofessional mixed-methods exploration.

関連する実験動画

ドーシェンヌ筋縮症におけるプレドニゾーン

関連する概念動画

関連記事